HSBC Holdings’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

HSBC Holdings’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-755,993	Closed	-$7.77M	–	3207
2022 Q4	$7.77M	Buy	755,993 +100,925	+15%	+$1.03M	0.01%	1072
2022 Q3	$6.6M	Hold	655,068	–	–	0.01%	1069
2022 Q2	$6.54M	Buy	+655,068	New	+$6.55M	0.01%	1088

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

HSBC Holdings's IQMD Position: Q1 2023 in Review

HSBC Holdings sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 755,993 shares — an estimated $7.77M sold.

HSBC Holdings first reported a position in IQMD in Q2 2022 and held it in 3 quarters. The position peaked at $7.77M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

HSBC Holdings reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
HSBC Holdings sold 755,993 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $7.77M.
HSBC Holdings first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 3 quarters.
HSBC Holdings's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $7.77M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.